
Collegium Pharmaceutical, Inc.
- Industry Drug Manufacturers - Specialty & Generic
- Sector Healthcare
- Market Cap
- Earnings
About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
COLL
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Collegium Pharmaceutical Non-GAAP EPS of $1.34 beats by $0.10, revenue of $136.7M misses by $2.84M
- Collegium Pharmaceutical Q3 2023 Earnings Preview
- Collegium pain med Nucynta gets US market exclusivity extension
- Collegium announces $50M accelerated share repurchase program
- Collegium Pharmaceutical Non-GAAP EPS of $1.26 beats by $0.04, revenue of $135.5M misses by $2.91M
- Collegium Pharmaceutical Q2 2023 Earnings Preview
- Collegium Pharmaceutical Non-GAAP EPS of $1.32 misses by $0.19, revenue of $144.8M beats by $6.47M
- Collegium Pharmaceutical Q1 2023 Earnings Preview
- FDA updates safety requirements for opioid pain meds
- Collegium Pharmaceutical Non-GAAP EPS of $1.09 misses by $0.17, revenue of $129.62M beats by $4.41M
- Collegium Pharmaceutical Q4 2022 Earnings Preview
- Collegium Pharmaceutical prices $210M senior notes
- Collegium stock falls ~10% after announcing intention for $175M notes offering
- Collegium Pharmaceutical GAAP EPS of $0.01 beats by $0.15, revenue of $127M beats by $2.64M
- Collegium Pharmaceutical Q3 2022 Earnings Preview
- Collegium Pharmaceutical downgraded to Neutral at H.C. Wainwright
- Collegium Pharmaceutical GAAP EPS of -$0.15 misses by $0.21, revenue of $123.55M beats by $2.33M
- Collegium Pharmaceutical Q2 2022 Earnings Preview
- Collegium Pharmaceutical GAAP EPS of -$0.39, revenue of $83.75M
- Collegium Pharmaceutical Q1 2022 Earnings Preview
PEERS
Earnings History
Date | EPS / Forecast | Revenue / Forecast | |
---|---|---|---|
February 24, 2022 | -0.4995 / 1.04 | 27.36M / 81.64M | |
November 4, 2021 | 0.8746 / 0.96 | 78.84M / 85.06M | |
August 5, 2021 | 0.8565 / 0.9629 | 82.94M / 84.61M | |
May 6, 2021 | 0.9806 / 1 | 87.72M / 81.78M |
Beat! |
February 25, 2021 | 0.93 / 0.9657 | 76.27M / 77.43M | |
November 5, 2020 | 1.03 / 0.8986 | 79.18M / 77.45M |
Beat! |
August 5, 2020 | 0.9467 / 0.86 | 78.06M / 74.42M |
Beat! |
May 7, 2020 | 0.8882 / 0.66 | 76.51M / 76.65M | |
February 27, 2020 | 0.1578 / 0.05 | 74.2M / 73.37M |
Beat! |
November 6, 2019 | 0.05 / 0.01 | 72.94M / 74.42M | |
August 7, 2019 | 0.1 / -0.05 | 75.04M / 75.85M | |
May 8, 2019 | -0.05 / -0.15 | 74.52M / 70.3M |
Beat! |
February 27, 2019 | -0.1 / -0.27 | 73.43M / 72.79M |
Beat! |
November 8, 2018 | -0.25 / -0.25 | 70.18M / 74.77M | |
August 8, 2018 | -0.15 / -0.39 | 73.06M / 72.14M |
Beat! |
May 9, 2018 | -0.57 / -0.6 | 63.75M / 51.96M |
Beat! |
March 7, 2018 | - / -0.57 | - / 10.19M | |
November 8, 2017 | -0.45 / -0.74 | 11.95M / 5.37M |
Beat! |
August 9, 2017 | -0.72 / -0.75 | 3.56M / 3.64M | |
May 10, 2017 | -0.79 / -0.8 | 2.17M / 3.57M | |
March 9, 2017 | -1.02 / -0.96 | 1.30M / 2.14M | |
November 10, 2016 | -1.13 / -1.04 | 408.0K / 1.32M |
Beat! |